David M Urech

Title: The Innovative Journey of David M. Urech

Introduction

David M. Urech, a prominent inventor based in Männedorf, Switzerland, has made significant contributions to the field of biomedicine with a remarkable portfolio of 47 patents. His work primarily focuses on advancing antibody technologies, which play a crucial role in therapeutic applications.

Latest Patents

Among Urech's notable inventions is the multispecific antibody that comprises a CD137 binding domain and a PDL1 binding domain. This invention not only encompasses the antibody itself but also includes pharmaceutical compositions and methods for its utilization. Furthermore, Urech's patent on a hetero-dimeric multi-specific antibody format targets both CD3 and human serum albumin (HSA). This innovative format combines multiple antibody variable domains and is designed to enhance therapeutic efficacy.

Career Highlights

David M. Urech has worked with several esteemed companies throughout his career. He has been a part of Esbatech, Alcon Biomedical Research Unit LLC, and Numab Therapeutics AG. His diverse experience across these organizations has played a pivotal role in shaping his expertise and innovative approach in the field of biomedical research.

Collaborations

Throughout his career, Urech has collaborated with notable professionals, including Leonardo Borras and Tea Gunde. These partnerships have likely contributed to the enriching exchange of ideas and accelerated the development of innovative solutions in antibody technologies.

Conclusion

David M. Urech continues to be a leading figure in the field of biomedicine, with his extensive patent portfolio highlighting his commitment to innovation. His groundbreaking work in multispecific antibodies marks a significant advancement in therapeutic methods, promising a brighter future for medical treatments.